European Archives - Page 128 of 1507 - European Medical Journal

Inside Virus Evolution: Interview with Edward Holmes

All human viruses ultimately come from animals, and humans transmit viruses to animals too, so it’s a two-way traffic.

Atopic Dermatitis Immune Signature in Depression - EMJ

Major Depressive Disorder Shares Immune Signature with AD

Major depressive disorder shares a Th2 immune signature with atopic dermatitis, highlighting dupilumab as a potential targeted therapy.

Vision Loss Risk with Semaglutide Use - EMJ

Semaglutide Associated with Optic Neuropathy and Vision Loss

New study links semaglutide to rare optic nerve damage, highlighting the need for increased awareness, monitoring, and informed prescribing.

Immunochemotherapy Timing Improves Survival - EMJ

Early Immunochemotherapy Timing Boosts Survival Outcomes

A Phase three trial shows early immunochemotherapy significantly improves survival and enhances CD8 T cell responses in advanced non small cell lung cancer.

Turning Male Mosquitoes into Dengue Control - EMJ

Scientists Are Turning Male Mosquitoes into Dengue Control

Releasing male Aedes aegypti mosquitoes infected with Wolbachia cut wild mosquito numbers in Singapore and lowered dengue infection risk.

lymphoma

Repeat R CHOP Improves Late Relapse Lymphoma Outcomes

A second course of R CHOP achieved durable responses in late relapse diffuse large B cell lymphoma, especially in patients relapsing more than 5 years after diagnosis.

lung cancer in never smokers

Lung Cancer in Never Smokers Needs a New Approach

Lung cancer in never smokers is rising, with distinct risks and biology, highlighting the need for tailored screening, prevention, and treatment.

5 minutes with Dr Stefanie Rau, Nestlé Health Science

Stefanie Rau, Global Medical Affairs Manager, Healthy Ageing, unpacks why it’s never too early to invest in your health.

STI prevention

New WHO Handbook for Global STI Prevention

The WHO’s new handbook offers practical guidance to strengthen STI prevention, improve care delivery, and address rising global infection rates effectively.

GLP 1 receptor agonists

GLP-1 Receptor Agonists Reduce Endometrial Cancer Risk

Large cohort study shows GLP-1 receptor agonists combined with progestins lower endometrial cancer risk and reduce hysterectomy incidence in women with benign uterine disease.